Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Event
NYU's Ambulatory Care Center at 240 East 38th Street, New York, NY, USA
We will be having a joint session with another community group, the alopecia areata group. Alopecia areata is an immune-related disease, like vitiligo, that causes hair loss usually in patches on the scalp and eyebrows.
The meeting will be on:
Thursday, April 13th, 2017 at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Avenues!
Note that as of now, the meeting time has been changed from 6:30 to 7PM
Spread the word and all family and friends are welcome!
Please let us know if you will be able to attend by email nyvitiligo@gmail.com.
We look forward to seeing you all there.
NY Vitiligo Community
FAQOther Questions
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
- Can Ginkgo Biloba help with vitiligo?
Ginkgo Biloba seems to be a simple, safe, inexpensive and fairly effective therapy for vitiligo. It is mostly effective in halting the progression of the disease. It can also sp...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.